Fiserv Inc. Stock Rises Wednesday, Outperforms Market

Xilio Therapeutics Inc

Change company Symbol lookup

Select an option...

XLO Xilio Therapeutics Inc

ORN Orion Group Holdings Inc

SMHI SEACOR Marine Holdings Inc

ASC Ardmore Shipping Corp

CCBC Chino Commercial Bancorp

INGR Ingredion Inc

PROF Profound Medical Corp

VWAGY Volkswagen AG

MLVF Malvern Bancorp Inc

GBCI Glacier Bancorp Inc

Company profile

Xilio Therapeutics, Inc. is a biotechnology company. The Company is focused on harnessing the immune system to achieve clinical responses for cancer patients. It offers a geographically precise solutions (GPS) platform to engineer molecules, including cytokines and other biologics, that are designed to enhance therapeutic index. Using its GPS platform, the Company is engaged in developing a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. Its product candidates include XTX101, XTX202, XTX301, and XTX401. XTX101 is a clinical-stage, tumor-selective anti-cytotoxic T-lymphocyte-associated protein (CTLA-4), monoclonal antibody (mAb), which is designed to improve upon the therapeutic index of existing anti-CTLA-4 therapies. XTX202 and XTX301 are an engineered form of interleukin 2 (IL-2) that is masked with a protein domain to prevent binding activity until the protein domain is cleaved off by tumor microenvironment (TME)-associated proteases.

Fiserv Inc. Stock Rises Wednesday, Outperforms Market

4:53 pm ET April 27, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Fiserv Inc. (FISV) rose 5.03% to $100.93 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.21% to 4,183.96 and the Dow Jones Industrial Average rising 0.19% to 33,301.93. Fiserv Inc. closed $23.14 short of its 52-week high ($124.07), which the company achieved on April 28th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Visa Inc. Cl A (V) rose 6.47% to $214.11, Mastercard Inc. (MA) rose 5.07% to $361.57, and Fidelity National Information Services Inc. (FIS) rose 3.75% to $98.84. Trading volume (5.8 M) eclipsed its 50-day average volume of 3.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 27, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

April 27, 2022 16:53 ET (20:53 GMT)